Your browser doesn't support javascript.
loading
Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide.
Liu, Na; Wang, Dongyuan; Lian, Chenshan; Zhao, Rongtong; Tu, Licheng; Zhang, Yichi; Liu, Jianbo; Zhu, Huilin; Yu, Mengying; Wan, Chuan; Li, Di; Li, Shuiming; Yin, Feng; Li, Zigang.
Afiliação
  • Liu N; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Room 301, Building E, Xili University, Shenzhen, P. R. China.
  • Wang D; Pingshan Translational Medicine Center, Shenzhen Bay Laboratory5F, No.9, Duxue Road, Nanshan, Shenzhen, P. R. China.
  • Lian C; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Room 301, Building E, Xili University, Shenzhen, P. R. China.
  • Zhao R; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 10th Floor, Old Out-Patient Building, Wuhan Union Hospital, Jianghan District, Wuhan, P. R. China.
  • Tu L; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Room 301, Building E, Xili University, Shenzhen, P. R. China.
  • Zhang Y; Pingshan Translational Medicine Center, Shenzhen Bay Laboratory5F, No.9, Duxue Road, Nanshan, Shenzhen, P. R. China.
  • Liu J; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Room 301, Building E, Xili University, Shenzhen, P. R. China.
  • Zhu H; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Room 301, Building E, Xili University, Shenzhen, P. R. China.
  • Yu M; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Room 301, Building E, Xili University, Shenzhen, P. R. China.
  • Wan C; Pingshan Translational Medicine Center, Shenzhen Bay Laboratory5F, No.9, Duxue Road, Nanshan, Shenzhen, P. R. China.
  • Li D; Shenzhen Second People's Hospital < street/>No. 3002, Sungang West Road, Futian District, Shenzhen, Shenzhen, P. R. China.
  • Li S; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Room 301, Building E, Xili University, Shenzhen, P. R. China.
  • Yin F; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Room 301, Building E, Xili University, Shenzhen, P. R. China.
  • Li Z; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Room 301, Building E, Xili University, Shenzhen, P. R. China.
Chembiochem ; 22(2): 340-344, 2021 01 15.
Article em En | MEDLINE | ID: mdl-32790056

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Compostos de Sulfidrila / Proteínas Proto-Oncogênicas c-bcl-2 / Proteínas Reguladoras de Apoptose Limite: Humans Idioma: En Revista: Chembiochem Assunto da revista: BIOQUIMICA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Compostos de Sulfidrila / Proteínas Proto-Oncogênicas c-bcl-2 / Proteínas Reguladoras de Apoptose Limite: Humans Idioma: En Revista: Chembiochem Assunto da revista: BIOQUIMICA Ano de publicação: 2021 Tipo de documento: Article